Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
14.31T | 13.32T | 14.31T | 11.76T | 8.01T | 6.89T | Gross Profit |
1.28T | 1.32T | 1.40T | 1.14T | 811.47B | 839.42B | EBIT |
381.84B | 525.42B | 702.28B | 544.82B | 169.93B | 278.16B | EBITDA |
938.57B | 1.28T | 1.23T | 1.08T | 553.18B | 615.54B | Net Income Common Stockholders |
989.45B | 1.06T | 1.13T | 914.72B | 335.46B | 391.51B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.49T | 902.72B | 2.16T | 2.13T | 1.49T | 1.62T | Total Assets |
12.52T | 16.90T | 15.38T | 14.92T | 12.52T | 11.81T | Total Debt |
4.75T | 4.78T | 5.04T | 4.88T | 4.75T | 4.93T | Net Debt |
3.68T | 3.88T | 3.65T | 3.75T | 3.68T | 3.87T | Total Liabilities |
7.69T | 9.13T | 8.82T | 9.13T | 7.69T | 7.75T | Stockholders Equity |
4.57T | 7.54T | 6.37T | 5.61T | 4.57T | 3.82T |
Cash Flow | Free Cash Flow | ||||
630.64B | 569.65B | 819.47B | 621.37B | 557.01B | 238.54B | Operating Cash Flow |
956.15B | 864.42B | 1.05T | 806.90B | 772.70B | 526.38B | Investing Cash Flow |
-182.25B | -427.55B | -178.34B | -181.19B | -322.47B | -185.23B | Financing Cash Flow |
-982.73B | -1.01T | -634.68B | -614.33B | -486.96B | -204.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $54.64B | 31.55 | 44.25% | 2.58% | 4.35% | 4.86% | |
80 Outperform | $55.81B | 14.63 | 14.74% | 2.37% | 0.34% | -8.45% | |
74 Outperform | $56.42B | 9.76 | 11.74% | 2.43% | 4.37% | 5.56% | |
73 Outperform | $56.94B | 18.06 | 26.13% | 1.62% | -2.39% | -7.80% | |
71 Outperform | $85.70B | 14.76 | 35.96% | 6.45% | 1.30% | -0.76% | |
71 Outperform | $62.96B | 16.85 | 25.69% | 1.08% | 0.14% | 202.13% | |
64 Neutral | $4.38B | 12.03 | 5.25% | 249.91% | 4.11% | -11.02% |